{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:26:12Z","timestamp":1771647972626,"version":"3.50.1"},"reference-count":26,"publisher":"Veterinary World","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018647","name":"RUDN University","doi-asserted-by":"publisher","award":["031622-0-000"],"award-info":[{"award-number":["031622-0-000"]}],"id":[{"id":"10.13039\/501100018647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011051","name":"Council on grants of the President of the Russian Federation","doi-asserted-by":"publisher","award":["MD1730.2021.3"],"award-info":[{"award-number":["MD1730.2021.3"]}],"id":[{"id":"10.13039\/501100011051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"abstract":"<jats:p>Background and Aim: Clinical strains of microorganisms, including pathogenic yeast-like fungi (YLF), are resistant to currently used antifungal agents. Thus, it is relevant to study the combinations of existing antimicrobial drugs and a medicinal extract of plant origin (farnesol). In previous studies, farnesol showed a relatively strong anti-biofilm effect against Candida albicans. This study aimed to determine how much the resistance profile of non-biofilm microorganisms can change.\n\nMaterials and Methods: Six clinical isolates of C. albicans and one reference strain were used to study the interaction of farnesol with the most used antimycotics. To determine the sensitivity of YLF to antimycotic drugs, such as nystatin (50 \u03bcg), amphotericin B (10 \u03bcg), ketoconazole (10 \u03bcg), clotrimazole (10 \u03bcg), voriconazole (10 \u03bcg), fluconazole (25 \u03bcg), miconazole (10 \u03bcg), and intraconazole (10 \u03bcg), the classic disk diffusion method was used. In the second stage, one of the six strains was used to simulate candidiasis of the gastrointestinal tract in an in vivo quail model. As an unusual experimental design, this study investigated the effects of pretreated C. albicans in quails, not the in vivo pathogenicity of C. albicans, after treatment with farnesol.\n\nResults: The resistance profiles of Candida strains did not improve with farnesol in all strains. All concentrations of farnesol (100, 50, and 25 \u03bcM) demonstrated a fungistatic effect (i.e., an increase in drug sensitivity) in 23 of 56 (7\u00d78) cases (41%). The remaining 54% demonstrated no changes in the resistance to antifungal drugs or deterioration of the indicators in rare cases (5%). At 100 \u03bcM farnesol, sensitivity improved in 33 of 56 cases (59%). Candidiasis or the severity of clinical disease of the quail digestive tract developed to a lesser extent if fungi were treated with farnesol.\n\nConclusion: Farnesol does not always show a positive result on single cells without biofilm in the laboratory. However, in a biofilm or an in vivo model with biofilms, farnesol can be considered a new antimycotic drug or an additive to existing antimycotics.<\/jats:p>","DOI":"10.14202\/vetworld.2022.848-854","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T07:13:18Z","timestamp":1649401998000},"page":"848-854","source":"Crossref","is-referenced-by-count":20,"title":["Enhancement of the antifungal activity of some antimycotics by farnesol and reduction of Candida albicans pathogenicity in a quail model experiment"],"prefix":"10.14202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-929X","authenticated-orcid":false,"given":"Nadezhda","family":"Sachivkina","sequence":"first","affiliation":[{"name":"Department of Microbiology and Virology, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-0149","authenticated-orcid":false,"given":"Alexander","family":"Senyagin","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Virology, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-2967","authenticated-orcid":false,"given":"Irina","family":"Podoprigora","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Virology, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0809-5871","authenticated-orcid":false,"given":"Elena","family":"Vasilieva","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Virology, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-6353","authenticated-orcid":false,"given":"Olga","family":"Kuznetsova","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2112-673X","authenticated-orcid":false,"given":"Arfenia","family":"Karamyan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, Agrarian Technological Institute, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-3949","authenticated-orcid":false,"given":"Alfia","family":"Ibragimova","sequence":"additional","affiliation":[{"name":"Department of General Pharmaceutical and Biomedical Technologies, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia; Department of Foreign Languages, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2958-5738","authenticated-orcid":false,"given":"Natalia","family":"Zhabo","sequence":"additional","affiliation":[{"name":"Department of Foreign Languages, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-8173","authenticated-orcid":false,"given":"Maria","family":"Molchanova","sequence":"additional","affiliation":[{"name":"Department of Foreign Languages, Institute of Medicine, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5308","published-online":{"date-parts":[[2022,4,8]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Rudenko, P., Vatnikov, Y., Sachivkina, N., Rudenko, A., Kulikov, E., Lutsay, V., Notina, E., Bykova, I., Petrov, A., Drukovskiy, S. and Olabode, I.R. (2021) Search for promising strains of probiotic microbiota isolated from different biotopes of healthy cats for use in the control of surgical infections. Pathogens, 10(6): 667.","DOI":"10.3390\/pathogens10060667"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Hallen-Adams, H.E. and Suhr, M.J. (2017) Fungi in the healthy human gastrointestinal tract. Virulence, 8(3): 352-358.","DOI":"10.1080\/21505594.2016.1247140"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Sachivkina, N., Podoprigora, I. and Bokov, D. (2021) Morphological characteristics of Candida albicans, Candida krusei, Candida guilliermondii, and Candida glabrata biofilms, and response to farnesol. Vet. World, 14(6): 1608-1614.","DOI":"10.14202\/vetworld.2021.1608-1614"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Sachivkina, N., Lenchenko, E., Blumenkrants. D., Ibragimova, A. and Bazarkina, O. (2020) Effects of farnesol and lyticase on the formation of Candida albicans biofilm. Vet. World, 13(6): 1030-1036.","DOI":"10.14202\/vetworld.2020.1030-1036"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Vatnikov, Y., Donnik, I., Kulikov, E., Karamyan, A., Sachivkina, N., Rudenko, P., Tumanyan, A., Khairova, N., Romanova, E. and Gurina, R. (2020) Research on the antibacterial and antimycotic effect of the phytopreparation Farnesol on biofilm-forming microorganisms in veterinary medicine. Int. J. Pharm. Res., 12: 1481-1492.","DOI":"10.31838\/ijpr\/2020.sp2.164"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Rudenko, P., Sachivkina, N., Vatnikov, Y., Shabunin, S., Engashev, S., Kontsevaya, S., Karamyan, A., Bokov, D., Kuznetsova, O. and Vasilieva, E. (2021) Role of microorganisms isolated from cows with mastitis in Moscow region in biofilm formation. Vet. World, 14(1): 40-48.","DOI":"10.14202\/vetworld.2021.40-48"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Lenchenko, E., Blumenkrants, D., Sachivkina, N., Shadrova, N. and Ibragimova, A. (2020) Morphological and adhesive properties of Klebsiella pneumoniae biofilms. Vet. World, 13(1): 197-200.","DOI":"10.14202\/vetworld.2020.197-200"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Sachivkina, N.P., Lenchenko, E.M. and Marakhova, A.I. (2019) Study of the formation of Candida albicans and Escherichia coli biofilms. Farmatsiya (Pharmacy), 68(7): 26-30.","DOI":"10.29296\/25419218-2019-07-05"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Jabra-Rizk, M.A., Shirtliff, M., James, C. and Meiller, T. (2006) Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res., 6(7): 1063-1073.","DOI":"10.1111\/j.1567-1364.2006.00121.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Langford, M.L., Kenneth, S.H., Nickerson, W. and Atkin, A.L. (2010) Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions. Antimicrob. Agents Chemother., 54(2): 940-942.","DOI":"10.1128\/aac.01214-09"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Wang, C., Park, J.-E., Choi, E.-S. and Kim, S.-W. (2016) Farnesol production in Escherichia coli through the construction of a farnesol biosynthesis pathway \u2013 application of PgpB and YbjG phosphatases. Biotechnol., J., 11: 1291-1297.","DOI":"10.1002\/biot.201600250"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Martins, M., Henriques, M., Azeredo, J., Rocha, S.M. and Coimbra, M.A. (2007) Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells. Eukaryot. Cell, 12(6): 2429-2436.","DOI":"10.1128\/ec.00252-07"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Sachivkina, N.P., Lenchenko, E.M., Mannapova, R.T., Strizhakov, A.A., Romanova, E.V. and Lukina, D.M. (2019) Candida biofilm modeling: Past and present. Farmatsiya (Pharmacy), 68(3): 18-22.","DOI":"10.29296\/25419218-2019-03-03"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Sachivkina, N.P., Kravtsov, E.G., Vasilyeva, E.A., Anokhina, I.V. and Dalin, M.V. (2009) Study of antimycotic activity of lyticase. Bull Exp. Biol. Med., 148(2): 214-216.","DOI":"10.1007\/s10517-009-0665-1"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Morozov, I.A., Sachivkina, N.P., Kravtsov, E.G., Vasilyeva, E.A., Anokhina, I.V., Yashina, N.V. and Dalin, M.V. (2011) Damaging effects of lyticase on Candida albicans and changes in the response of rat alveolar macrophages to the contact with yeast-like fungi. Bull. Exp. Biol. Med., 151(6): 705-708.","DOI":"10.1007\/s10517-011-1421-x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Sachivkina, N.P., Kravtsov, E.G., Vasileva, E.A., Anokchina, I.V. and Dalin, M.V. (2010) Efficiency of lyticase (bacterial enzyme) in experimental candidal vaginitis in mice. Bull. Exp. Biol. Med., 149(6): 727-730.","DOI":"10.1007\/s10517-010-1037-6"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals of the Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council. (2011) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC, USA. Available from: https:\/\/grants.nih.gov\/grants\/olaw\/guide-for-the-care-anduse-of-laboratory-animals.pdf. Retrieved on 28-12-2020.","DOI":"10.17226\/25801"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Sachivkina, N., Lenchenko, E., Strizakov, A., Zimina, V., Gnesdilova, L., Gavrilov, V., Byakhova, V., Germanova, S., Zharov, A. and Molchanova, M. (2018) The Evaluation of formation of biomembrane by microscopic Fungi of the Candida Genus. Int. J. Pharm. Res., 10(4): 738-744.","DOI":"10.31838\/ijpr\/2018.10.04.128"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Rossignol, T., Logue, M.E., Reynolds, K., Grenon, M., Lowndes, N.F. and Butler G. (2007) Transcriptional response of Candida parapsilosis following exposure to Farnesol. Antimicrob. Agents Chemother., 51(7): 2304-2312.","DOI":"10.1128\/aac.01438-06"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Hirayama, T., Miyazaki, T., Sumiyoshi, M., Ashizawa, N., Takazono, T., Yamamoto, K., Imamura, Y., Izumikawa, K., Yanagihara, K., Kohno, S. and Mukae, H. (2021) ERG3-Encoding Sterol C5, 6-DESATURASE in Candida albicans is required for virulence in an enterically infected invasive candidiasis mouse model. Pathogens, 10(1): 23.","DOI":"10.3390\/pathogens10010023"},{"key":"ref20","unstructured":"Lenchenko, E., Blumenkrants, D., Vatnikov, Y., Kulikov, E., Khai, V., Sachivkina, N., Gnezdilova, L., Sturov, N., Sakhno, N., Kuznetsov, V., Strizhakov, A. and Mansur, T. (2020) Poultry Salmonella sensitivity to antibiotics. Sys. Rev. Pharm., 11(2): 170-175."},{"key":"ref21","unstructured":"Sachivkina, N.P., Karamyan, A.S., Kuznetsova, O.M., Byakhova, V.M., Bondareva, I.B. and Molchanova M.A. (2019) Development of therapeutic transdermal systems for microbial biofilm destruction. FEBS Open Bio, 9(S1): 386."},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Ramage, G., Saville, S.P., Wickes, B.L. and Lopez-Ribot, J.L. (2002) Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol., 68(11): 5459-5463.","DOI":"10.1128\/aem.68.11.5459-5463.2002"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Jacobsen, I.D., Wilson, D., Wachtler, B., Brunke, S.L., Naglik, J.R. and Hube, B. (2012) Candida albicans dimorphism as a therapeutic target. Expert Rev. Anti Infect. Ther., 10(1): 85-93.","DOI":"10.1586\/eri.11.152"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Witchley, J.N., Penumetcha, P., Abon, N.V., Woolford, C.A., Mitchell, A.P. and Noble, S.M. (2019) Candida albicans morphogenesis programs control the balance between gut commensalism and invasive infection. Cell Host Microbe, 25(3): 432-443.","DOI":"10.1016\/j.chom.2019.02.008"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Sachivkina, N., Vasilieva, E., Lenchenko, E., Kuznetsova, O., Karamyan, A., Ibragimova, A., Zhabo, N. and Molchanova, M. (2022) Reduction in pathogenicity in yeast-like fungi by farnesol in quail model. Animals, 12(4): 489.","DOI":"10.3390\/ani12040489"}],"container-title":["Veterinary World"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/April-2022\/5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/April-2022\/5.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/April-2022\/5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T11:19:37Z","timestamp":1668165577000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.veterinaryworld.org\/Vol.15\/April-2022\/5.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":26,"URL":"https:\/\/doi.org\/10.14202\/vetworld.2022.848-854","relation":{},"ISSN":["2231-0916","0972-8988"],"issn-type":[{"value":"2231-0916","type":"electronic"},{"value":"0972-8988","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,8]]}}}